MAP microba life sciences limited

What "strong growth" ?The testing services business is yet to...

  1. 10,128 Posts.
    lightbulb Created with Sketch. 1041
    What "strong growth" ?

    The testing services business is yet to perform. Growth is sluggish and not what was projected when it IPO'd.

    The directors then decide to acquire revenue by buying a business in the UK that doesn't make a profit and to do that they do a heavily dilutive cap raising at 23 cents which was a 30% discount to the then prevailing share price.

    Shareholders have been done over. The next quarterly is likely to show a continuation of big cash burn.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.9¢
Change
-0.003(3.26%)
Mkt cap ! $45.83M
Open High Low Value Volume
9.5¢ 9.5¢ 8.9¢ $67.73K 746.9K

Buyers (Bids)

No. Vol. Price($)
2 69744 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 65000 2
View Market Depth
Last trade - 15.59pm 01/08/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.